General | Carbohydrate O/F | Substrate utilisation | Enzymes | Metabolites | Antibiotics

Overview


  • Bifidobacterium myosotis is a Gram-positive, non-spore-forming, anaerobic, non-motile, pleiomorph rod-shaped bacterium. It has been detected in at least 1 gut microbiome compilation study or metastudy. The DNA G+C content is 65.1%. Bifidobacterium myosotis is probably a rare gut coloniser. (Michelini2016b)



  • This organism has been recovered from faeces of the common marmoset. Pathogenicity status unknown, or very unlikely to be pathogenic. A possible gut commensal.

  • GENERAL CHARACTERISTICS (Michelini2016b);
    Character Response
  • Substrates hydrolysed or digested:
  • aesculin; urea;
  • pH
  • Acidity tolerance:
  • tolerates pH 4.5; tolerates pH 8.0; Grows optimally at pH 7.
  • 🌡
  • Temperature tolerance:
  • grows at 25℃; grows at 46℃; Grows optimally at 40℃.
  • H+
  • Acid from carbohydrates usually produced:
  • L-arabinose; glucose; xylose; cellubiose; lactose; maltose; melibiose; sucrose; trehalose; salicin;
  • ±
  • Strain-dependent acid from carbs:
  • fructose; galactose; mannose; amygdalin; D-turanose; mannitol; methyl xyloside;
  • Active enzymes:
  • Ala arylamidase; arginine dihydrolase; Gly arylamidase; His arylamidase; Leu arylamidase; Leu-Gly arylamidase; Phe arylamidase; Pro arylamidase; Ser arylamidase; Tyr arylamidase; urease;

  • SPECIAL FEATURES (Michelini2016b);
    Character Response
  • Metabolites not produced:
  • indole;
  • Haemolysis:
  • absent
  • Nitrate:
  • not reduced

  • Details


    GENERAL
    Lineage Physiology General Growth Tolerances Hydrol./digest./degr.
    Phylum:  Actinobacteria Class:  Actinobacteria Order:  Bifidobacteriales Family:  Bifidobacteriaceae Genus:  Bifidobacterium Gram stain:  + O2 Relation.:  anaerobic Spore:  No spore Motility:  Sessile Morphology:  Pleiomorph rod
    Health:  Unknown
    Source:  faeces of the common marmoset
    DNA G+C(%):  65.1
    Opt. T:  40℃
    Lower T(℃):  25(+)
    High T(℃):  46(+)
    Opt. pH:  7
    pH 4.2-5.9:  4.5(+)
    pH 6.0-8.0:  8.0(+)
    Aesculin:  + Urea:  +

    CARBOHYDRATE ACID FORMATION
    Monosaccharide O/F Oligosaccharide O/F Polysaccharide O/F Polyol O/F Other O/F
    D-Arabinose:  neg L-Arabinose:  + Fructose:  d D-Fucose:  neg Galactose:  d Glucose:  + Mannose:  d D-Lyxose:  neg Rhamnose:  neg Ribose:  neg Sorbose:  neg D-Tagatose:  neg Xylose:  + L-Xylose:  neg Cellubiose:  + Gentiobiose:  neg Lactose:  + Maltose:  + Melezitose:  w Melibiose:  + Sucrose:  + Trehalose:  + Turanose:  d Amygdalin:  d Glycogen:  neg Inulin:  neg Starch:  neg Adonitol:  neg D-Arabitol:  neg L-Arabitol:  neg Dulcitol:  neg Erythritol:  neg Glycerol:  neg Inositol:  neg Mannitol:  d Sorbitol:  neg Xylitol:  neg Arbutin:  neg Gluconate:  neg 2-Ketogluconate:  neg 5-Ketogluconate:  neg Me-α-D-Glc:  neg Me-α-D-Mann:  neg Me-Xyloside:  d NAc-α-GA:  neg Salicin:  +

    ENZYME ACTIVITY
    Enzymes: General Enzymes: Carbohydrate Enzymes: Protein Enzymes: Arylamidases Enzymes: Esters/fats
    Oxidase:  neg Catalase:  neg Urease:  + α-Arab:  neg Ac-β-glcamnd:  neg α-Fucosidase:  neg α-Galactosidase:  neg β-Galactosidase:  neg α-Glucosidase:  neg β-Glucosidase:  neg β-Glucuronidase:  neg α-Mannosidase:  neg ArgDH:  + Chymotrypsin:  neg Trypsin:  neg AlanineAA:  + ArgAA:  neg CystineAA:  neg GluGluAA:  neg GlyAA:  + HisAA:  + LeuAA:  + LeuGlyAA:  + ProAA:  + PheAA:  + SerAA:  + TyrAA:  + ValAA:  neg AlkalineP:  neg EstLip(C8):  neg Lipase(C14):  neg

    METABOLITES - PRODUCTION & USE
    Fuel Usable Metabolites Metabolites Released Special Products Compounds Produced

    Indole:  neg

    References


    SPECIFIC REFERENCES FOR BIFIDOBACTERIUM MYOSOTIS
  • Michelini2016b - Bifidobacterium myosotis sp. nov., Bifidobacterium tissieri sp. nov. and Bifidobacterium hapali sp. nov., isolated from faeces of baby common marmosets (Callithrix jacchus L.).
  • Michelini2015 - Isolation and identification of cultivable Bifidobacterium spp. from the faeces of 5 baby common marmosets (Callithrix jacchus L.).
  • ...............................
  • GUT MICROBIOME COMPILATIONS AND METASTUDIES FOR BIFIDOBACTERIUM MYOSOTIS
  • Byrd2020 - Stability and dynamics of the human gut microbiome and its association with systemic immune traits.
  • ...............................